☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Vifor
Vifor & Cara’s Kapruvia (difelikefalin) Receive EC’s Approval for the Treatment of Pruritus in Hemodialysis Patients
April 28, 2022
Vifor and Angion Report Results of ANG-3777 in P-II (GUARD) Trial for Cardiac Surgery Associated Acute Kidney Injury
December 10, 2021
PharmaShots Weekly Snapshots (October 25 - 29, 2021)
October 29, 2021
Insights+: The US FDA New Drug Approvals in August 2021
September 16, 2021
PharmaShots Weekly Snapshots (August 23, 27, 2021)
August 27, 2021
Cara and Vifor's Korsuva (difelikefalin) Receive the US FDA's Approval for the Treatment of Moderate-to-Severe Pruritus Due to CKD...
August 25, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.